FDA Gives Broad Approval to Gene Therapy for Rare Neurologic Disease

(MedPage Today) — The FDA approved the intrathecal gene therapy onasemnogene abeparvovec (Itvisma) to treat spinal muscular atrophy (SMA) in adults and pediatric patients 2 years and older with a confirmed mutation in the survival motor neuron…